Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,551 total articles
Minerals Technologies Inc. has initiated a private offering of $400 million in senior notes due 2034, aiming to redeem its outstanding 5.000% senior notes due 2028 and cover related transaction costs. The offering targets qualified institutional buyers and non-U.S. persons under exemptions from registration. There is no guarantee the offering will …
nVent Electric plc has completed the acquisition of Maverick Power for $1.75 billion, with additional earn-out potential, expanding its power distribution solutions and offerings tailored for data centers. This strategic move enhances nVent's position in the high-growth infrastructure sector by adding new power architectures and system-level soluti…
XPO, Inc., a leading North American freight transportation company, has opened two new service centers in Mesa, Arizona, and Cameron, Missouri. These new facilities enhance XPO's capacity in the fast-growing Phoenix and Kansas City metropolitan freight markets, supporting increasing demand driven by industrial investment and cross-border trade. The…
InflaRx N.V., a biopharmaceutical company specializing in complement system-targeted anti-inflammatory therapeutics, announced the appointment of Dr. Gabriela Alperovich as Senior Vice President and Global Head of Clinical Development. Dr. Alperovich brings over 20 years of clinical development leadership with expertise in immune-inflammatory and r…
Streamex Corp. (NASDAQ: STEX), focused on commodity market tokenization, announced CEO Henry McPhie's October trip to Singapore and Hong Kong for multiple digital asset and investment events. The tour aims to engage institutional investors and partners to expand adoption of Streamex's gold-backed tokenized security, GLDY, and strengthen presence in…
Arbutus Biopharma Corporation announced the final results of its modified Dutch auction tender offer to repurchase up to US$230 million of its common shares. The company accepted 46 million shares at US$5.00 each, representing approximately 23% of its outstanding shares. The offer was oversubscribed, resulting in proration of shares tendered at or …
Wave Life Sciences announced alignment with FDA on a two-year registrational trial plan for WVE-006, an RNA editing therapy targeting alpha-1 antitrypsin deficiency (AATD). The FDA supports a one-year interim analysis for potential accelerated approval based on biomarkers. WVE-006 aims to treat both lung and liver manifestations of AATD with a subc…
FTI Consulting has appointed Christina Morris as a Senior Managing Director in its Healthcare Risk Management & Advisory practice to enhance AI and automation capabilities in healthcare compliance and risk management. Morris brings over 25 years of experience in driving technology-enabled transformations, including AI and hyperautomation, aiming to…
Helus Pharma, previously known as Cybin Inc., has legally changed its name to reflect its transition from a clinical-stage discovery company to a commercial-ready pharmaceutical company focused on developing novel serotonergic agonists (NSAs) for mental health treatment. The company maintains its listing on Nasdaq and Cboe Canada under the ticker H…
Edible Garden AG Incorporated has entered into a contract to purchase a 6.2-acre property in Webster City, Iowa, to establish its Prairie Hills ready-to-drink (RTD) manufacturing platform. This acquisition transitions the company from tenant to owner, providing greater control over the strategic manufacturing asset aimed at expanding its Farm-to-Fo…
Unicycive Therapeutics, a Nasdaq-listed clinical-stage biotech focused on kidney disease treatments, appointed Meredith Manning, an experienced biopharmaceutical executive, to its Board of Directors. Her expertise in commercialization and successful drug launches is expected to support Unicycive’s progression toward potential FDA approval of its le…
Lantronix Inc. announced that its Open-Q 8550CS System-on-Module (SOM) has been added to the U.S. Department of War's Blue UAS Framework, a vetted list of NDAA-compliant components for unmanned aircraft systems. This listing validates the security and supply chain integrity of Lantronix's AI compute module, simplifying procurement for drone OEMs in…
OrthoPediatrics Corp., a company specializing in pediatric orthopedic products, sponsored the 10th Pediatric Orthopedic Surgical Techniques (POST) Course. The event featured expert instruction, hands-on training, and networking for senior residents, fellows, and early-career surgeons. It also introduced a new companion manual to enhance educational…
Sight Sciences has announced the commercial availability of the OMNI Ultra Surgical System, an advanced next-generation device expanding its pioneering ab interno canaloplasty platform. Showcased at the 2026 American Academy of Ophthalmology meeting, OMNI Ultra enhances procedural versatility and control to treat primary open-angle glaucoma by addr…
Origin Agritech Limited announced the sale of its 70.5% equity interest in its Xinjiang Originbo seed production base to Hunan Xindaxin Limited for approximately US$15 million. Concurrently, a five-year lease-back agreement ensures operational continuity at the production facility, preserving seed supply stability. The proceeds will be deployed to …
Anfield Energy received approval from the Colorado Division of Reclamation, Mining and Safety on the reclamation permit application for its JD-8 uranium and vanadium mine, a key asset in Anfield's Monogram Mesa Mine Complex. The decision clears state-level permitting, with federal approvals underway, targeting a restart of production by mid-2027. T…
USA Rare Earth, a Nasdaq-listed rare earth and critical minerals company, has completed its CEO succession with Thras Moraitis stepping into the role. Moraitis aims to integrate the company's diverse operations across mining, processing, and magnet manufacturing in the US, Brazil, and UK. The company is structured into three business units to enhan…
BioStem Technologies, Inc., a regenerative medicine company, announced the issuance of a new U.S. patent and multiple patent allowances in the U.S. and Mexico covering its placental and umbilical tissue allograft technologies. These patents focus on wound care, surgical, and joint treatment applications, strengthening the company's intellectual pro…
Generate Biomedicines and Roswell Park Comprehensive Cancer Center have initiated a Phase 1 clinical trial for GB-5267, an investigational AI-designed IL-18 armored CAR T-cell therapy aimed at treating platinum-resistant ovarian cancer by targeting the MUC16 antigen. The approach focuses on overcoming solid tumor microenvironment challenges without…
Kyntra Bio announces the appointment of Andrew E. Singer, MBA, a seasoned biotechnology finance and strategy executive, to its Board of Directors and Audit Committee. The move aims to leverage Mr. Singer's extensive expertise to advance the company's rare disease and oncology pipeline and support strategic priorities. Concurrently, long-serving boa…
Iovance Biotherapeutics announces the appointment of Dr. Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer to lead clinical development efforts for its tumor infiltrating lymphocyte (TIL) therapies in multiple solid tumor cancers. Dr. Berkowitz brings extensive experience in cancer drug development and regulatory approvals, previously holding l…
Monte Rosa Therapeutics announced positive results from its GFORCE-1 Phase 1 study of MRT-8102, a NEK7-directed molecular glue degrader targeting inflammatory pathways linked to atherosclerotic cardiovascular disease (ASCVD). In obese subjects with elevated cardiovascular risk, MRT-8102 demonstrated robust NEK7 degradation and significant reduction…
Medifast's Trilivy metabolic health system identifies five often overlooked signs of poor metabolic health and offers a structured framework, incorporating its MetaVantage Reset Formula and coaching support, to improve metabolic outcomes. A clinical trial showed 14% reduction in visceral fat and 98% lean mass retention over 16 weeks, supporting the…
Fervo Energy announced that its first GeoBlock at Cape Station in Utah achieved commercial operation ahead of schedule, generating 33 MW of net power and starting revenue under its power purchase agreement. This milestone establishes Fervo's leadership in enhanced geothermal systems (EGS) and signals the viability of reliable, carbon-free power pro…
Fate Therapeutics announced that its management will participate in major healthcare investor conferences in the fourth quarter of 2026, including the Jefferies Global Healthcare Conference in London and the Piper Sandler Annual Healthcare Conference in New York. The company focuses on developing induced pluripotent stem cell-derived cellular immun…
